nifekalant hydrochloride has been researched along with Cardiomyopathy, Dilated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Tao, L; Xiao, H | 1 |
| Bando, K; Okamura, H; Ueda, HI | 1 |
2 other study(ies) available for nifekalant hydrochloride and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Long-term nifekalant use in a patient with dilated cardiomyopathy and recurrent ventricular tachycardia.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Humans; Male; Pyrimidinones; Tachycardia, Ventricular | 2022 |
Crystals in the heart.
Topics: Adult; Cardiomyopathy, Dilated; Crystallization; Echocardiography, Transesophageal; Female; Heart Diseases; Humans; Infusions, Intravenous; Potassium Channel Blockers; Pyrimidinones; Thrombosis | 2004 |